Consumer Driven Health Care

HealthEquity's CEO predicts plan participants' adoption rates will rise as the firm's relationships with health plans mature.

Five of the suits were filed by Esperion Therapeutics, which seeks to stop competitors from selling generic versions of the company's cholesterol drug Nexletol.

The percentage of older adults who had a dental visit decreased from 65.4% among those aged 65 to 74 to 53.3% among those age 85 and older.

As the drugmaker moves into Phase III studies for survodutide, its new GLP-1 obesity drug, Walgreens will use its community pharmacies as clinical trial sites, aiming to improve access and address equitable health representation.

Among low-income families, mean total health care spending was $3,163 in 2007 and $3247 in 2019.

Although employees weigh a number of factors when making health plan decisions, cost remains the overriding factor, and employer contributions are the main reason why employees choose an HSA, says a new survey.

A House Committee approved the Biosecure Act to end U.S. contracting with Chinese firms deemed a threat to national security, but filling the void left by Chinese companies may be a challenge to U.S. drug development.

Incorporating value-based primary care models into your portfolio isn't just about expanding your offerings; it's about solidifying your role as a trusted advisor and helping your clients build innovative benefits packages that reflect their businesses.